메뉴 건너뛰기




Volumn 40, Issue 2, 2011, Pages 116-121

Hyperuricaemia and accelerated reduction in renal function

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; URIC ACID;

EID: 79952427053     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2010.507218     Document Type: Article
Times cited : (46)

References (35)
  • 1
    • 68849115038 scopus 로고    scopus 로고
    • Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate
    • See LC, Kuo CF, Chuang FH, Li HY, Chen YM, Chen HW, et al. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate. J Rheumatol 2009;36:1691-8.
    • (2009) J. Rheumatol. , vol.36 , pp. 1691-1698
    • See, L.C.1    Kuo, C.F.2    Chuang, F.H.3    Li, H.Y.4    Chen, Y.M.5    Chen, H.W.6
  • 2
    • 33751215875 scopus 로고    scopus 로고
    • The association between serum uric acid level and long-term incidence of hypertension: Population-based cohort study
    • DOI 10.1038/sj.jhh.1002095, PII 1002095
    • Shankar A, Klein R, Klein BE, Nieto FJ. The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens 2006;20:937-45. (Pubitemid 44782827)
    • (2006) Journal of Human Hypertension , vol.20 , Issue.12 , pp. 937-945
    • Shankar, A.1    Klein, R.2    Klein, B.E.K.3    Nieto, F.J.4
  • 3
    • 73349138594 scopus 로고    scopus 로고
    • Uric acid: A novel mediator and marker of risk in chronic kidney disease?
    • Feig DI. Uric acid: a novel mediator and marker of risk in chronic kidney disease? Curr Opin Nephrol Hypertens 2009;18:526-30.
    • (2009) Curr. Opin. Nephrol. Hypertens , vol.18 , pp. 526-530
    • Feig, D.I.1
  • 4
    • 44649171747 scopus 로고    scopus 로고
    • High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes
    • Rosolowsky ET, Ficociello LH, Maselli NJ, Niewczas MA, Binns AL, Roshan B, et al. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol 2008;3:706-13.
    • (2008) Clin. J. Am. Soc. Nephrol. , vol.3 , pp. 706-713
    • Rosolowsky, E.T.1    Ficociello, L.H.2    Maselli, N.J.3    Niewczas, M.A.4    Binns, A.L.5    Roshan, B.6
  • 5
    • 34948833859 scopus 로고    scopus 로고
    • Serum uric acid as a risk factor for cardiovascular and renal disease: An old controversy revived
    • Viazzi F, Leoncini G, Ratto E, Pontremoli R. Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived. J Clin Hypertens (Greenwich) 2006;8:510-18.
    • (2006) J. Clin. Hypertens (Greenwich) , vol.8 , pp. 510-518
    • Viazzi, F.1    Leoncini, G.2    Ratto, E.3    Pontremoli, R.4
  • 7
    • 40649109031 scopus 로고    scopus 로고
    • Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The mild to moderate kidney disease (MMKD) study
    • Sturm G, Kollerits B, Neyer U, Ritz E, Kronenberg F. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp Gerontol 2008;43:347-52.
    • (2008) Exp. Gerontol. , vol.43 , pp. 347-352
    • Sturm, G.1    Kollerits, B.2    Neyer, U.3    Ritz, E.4    Kronenberg, F.5
  • 8
    • 0019202531 scopus 로고
    • Serum uric acid in essential hypertension: An indicator of renal vascular involvement
    • Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, Aristimuno GG. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med 1980;93:817-21. (Pubitemid 11197783)
    • (1980) Annals of Internal Medicine , vol.93 , Issue.6 , pp. 817-821
    • Messerli, F.H.1    Frohlich, E.D.2    Dreslinski, G.R.3
  • 10
    • 4544313843 scopus 로고    scopus 로고
    • Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort
    • DOI 10.1053/j.ajkd.2004.06.006, PII S0272638604009345
    • Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004;44:642-50. (Pubitemid 39237608)
    • (2004) American Journal of Kidney Diseases , vol.44 , Issue.4 , pp. 642-650
    • Iseki, K.1    Ikemiya, Y.2    Inoue, T.3    Iseki, C.4    Kinjo, K.5    Takishita, S.6
  • 11
    • 0034939069 scopus 로고    scopus 로고
    • Hyperuricemia and gout in Taiwan: Results from the nutritional and health survey in Taiwan (1993-96)
    • Chang HY, Pan WH, Yeh WT, Tsai KS. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol 2001;28:1640-6.
    • (2001) J. Rheumatol. , vol.28 , pp. 1640-1646
    • Chang, H.Y.1    Pan, W.H.2    Yeh, W.T.3    Tsai, K.S.4
  • 13
    • 0032954651 scopus 로고    scopus 로고
    • The 10-year incidence of renal insufficiency in people with type 1 diabetes
    • DOI 10.2337/diacare.22.5.743
    • Klein R, Klein BE, Moss SE, Cruickshanks KJ, Brazy PC. The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 1999;22:743-51. (Pubitemid 29220773)
    • (1999) Diabetes Care , vol.22 , Issue.5 , pp. 743-751
    • Klein, R.1    Klein, B.E.K.2    Moss, S.E.3    Cruickshanks, K.J.4    Brazy, P.C.5
  • 14
    • 33846419122 scopus 로고    scopus 로고
    • Hyperuricemia and incidence of hypertension among men without metabolic syndrome
    • DOI 10.1161/01.HYP.0000254480.64564.b6, PII 0000426820070200000012
    • Krishnan E, Kwoh CK, Schumacher HR, Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007;49:298-303. (Pubitemid 46143005)
    • (2007) Hypertension , vol.49 , Issue.2 , pp. 298-303
    • Krishnan, E.1    Kwoh, C.K.2    Schumacher, H.R.3    Kuller, L.4
  • 15
    • 0035207070 scopus 로고    scopus 로고
    • Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects
    • DOI 10.1291/hypres.24.691
    • Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001;24:691-7. (Pubitemid 33133783)
    • (2001) Hypertension Research , vol.24 , Issue.6 , pp. 691-697
    • Iseki, K.1    Oshiro, S.2    Tozawa, M.3    Iseki, C.4    Ikemiya, Y.5    Takishita, S.6
  • 17
    • 12344260958 scopus 로고    scopus 로고
    • Uric acid and chronic renal disease: Possible implication of hyperuricemia on progression of renal disease
    • DOI 10.1016/j.semnephrol.2004.10.001, PII S0270929504001913, Uric Acid in Cardiovascular and Renal Disease
    • Kang DH, Nakagawa T. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease. Semin Nephrol 2005;25:43-9. (Pubitemid 40128148)
    • (2005) Seminars in Nephrology , vol.25 , Issue.1 , pp. 43-49
    • Kang, D.-H.1    Nakagawa, T.2
  • 18
    • 0018755955 scopus 로고
    • Renal outcomes of gout and hyperuricemia
    • DOI 10.1016/0002-9343(79)90076-7
    • Fessel WJ. Renal outcomes of gout and hyperuricemia. Am J Med 1979;67:74-82. (Pubitemid 9230708)
    • (1979) American Journal of Medicine , vol.67 , Issue.1 , pp. 74-82
    • Fessel, W.J.1
  • 19
    • 49049136122 scopus 로고
    • Impaired renal function in gout. Its association with hypertensive vascular disease and intrinsic renal disease
    • DOI 10.1016/0002-9343(82)90593-9
    • Yu TF, Berger L. Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease. Am J Med 1982;72:95-100. (Pubitemid 12090792)
    • (1982) American Journal of Medicine , vol.72 , Issue.1 , pp. 95-100
    • Yu, T.F.1    Berger, L.2
  • 21
    • 29244447160 scopus 로고    scopus 로고
    • Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level
    • DOI 10.1053/j.ajkd.2005.10.006, PII S0272638605015180
    • Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006;47:51-9. (Pubitemid 41828266)
    • (2006) American Journal of Kidney Diseases , vol.47 , Issue.1 , pp. 51-59
    • Siu, Y.-P.1    Leung, K.-T.2    Tong, M.K.-H.3    Kwan, T.-H.4
  • 26
    • 0038579374 scopus 로고    scopus 로고
    • Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2
    • DOI 10.1161/01.HYP.0000072820.07472.3B
    • Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003;41:1287-93. (Pubitemid 36706079)
    • (2003) Hypertension , vol.41 , Issue.6 , pp. 1287-1293
    • Kanellis, J.1    Watanabe, S.2    Li, J.H.3    Kang, D.H.4    Li, P.5    Nakagawa, T.6    Wamsley, A.7    Sheikh-Hamad, D.8    Lan, H.Y.9    Feng, L.10    Johnson, R.J.11
  • 30
    • 77953530672 scopus 로고    scopus 로고
    • Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: A cross-sectional study
    • Kuo CF, Yu KH, Luo SF, Ko YS, Wen MS, Lin YS, et al. Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a cross-sectional study. Rheumatology (Oxford) 2010;49:1189-96.
    • (2010) Rheumatology (Oxford) , vol.49 , pp. 1189-1196
    • Kuo, C.F.1    Yu, K.H.2    Luo, S.F.3    Ko, Y.S.4    Wen, M.S.5    Lin, Y.S.6
  • 31
    • 0016790889 scopus 로고
    • Hyperuricemia in coronary, cerebral and peripheral arterial disease: An explanation
    • Newland H. Hyperuricemia in coronary, cerebral and peripheral arterial disease: an explanation. Med Hypotheses 1975;1:152-5.
    • (1975) Med. Hypotheses , vol.1 , pp. 152-155
    • Newland, H.1
  • 33
    • 11244253742 scopus 로고    scopus 로고
    • Resurrection of uric acid as a causal risk factor in essential hypertension
    • DOI 10.1161/01.HYP.0000150785.39055.e8
    • Johnson RJ, Feig DI, Herrera-Acosta J, Kang DH. Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 2005;45:18-20. (Pubitemid 40066407)
    • (2005) Hypertension , vol.45 , Issue.1 , pp. 18-20
    • Johnson, R.J.1    Feig, D.I.2    Herrera-Acosta, J.3    Kang, D.-H.4
  • 35
    • 58049213912 scopus 로고    scopus 로고
    • Longitudinal analysis of performance of estimated glomerular filtration rate as renal function declines in chronic kidney disease
    • Lee D, Levin A, Roger SD, McMahon LP. Longitudinal analysis of performance of estimated glomerular filtration rate as renal function declines in chronic kidney disease. Nephrol Dial Transplant 2009;24:109-16.
    • (2009) Nephrol. Dial. Transplant. , vol.24 , pp. 109-116
    • Lee, D.1    Levin, A.2    Roger, S.D.3    McMahon, L.P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.